Based on these findings, the authors proposed that excessive APP activation by amyloid peptides might contribute to hippocampal hyperactivity under pathological conditions, supporting the hypothesis that normal APP-Gαo interactions are altered in AD. This evidence concerns the gene APP and Alzheimer disease.